­Background Current glucose monitoring solutions include minimally invasive continuous blood glucose monitoring using implantable enzymatic sensors. However, biomacromolecule binding can cause foreign body reactions, and long-term implanted sensors can give rise to biocompatibility issues. These drawbacks make difficult the clinical promotion of...